Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Results of animal studies indicate ability of GeneSwitch to regulate gene therapy

Jan. 22, 1999

MorphoSys enters licensing agreement with Chiron for HuCAL

Jan. 22, 1999

Pharmacopeia enters research collaboration with Pharmacia & Upjohn

Jan. 21, 1999

AxyS and RPR enter second collaborative agreement

Jan. 21, 1999

PDL issues further licenses under its antibody humanization patents

Jan. 20, 1999

Idun obtains rights to technology with application to HIV and other diseases

Jan. 20, 1999

New neurological and immunological therapies basis of Neurocrine Biosciences-Caliper collaboration

Jan. 19, 1999

LeukoSite, Warner-Lambert collaborate on integrin antagonist research

Jan. 19, 1999

Targeted Genetics, Sangamo combine two novel technologies for drug discovery

Jan. 19, 1999

Palatin and Nihon Medi-Physics intend to develop radiopharmaceutical products

Jan. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...